Global Drug Delivery Infusion And Injection Technologies Market Forecast To Exceed $17.6 Billion By 2020
The adoption of innovative technologies for medication infusion and injection will ignite growth in mature markets.
HUNTINGTON BEACH, Calif., June 4, 2015 /PRNewswire/ -- A new analysis by Life Science Intelligence (LSI), Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015, has concluded that despite efforts to push back on the cost of acquiring new medical devices, innovative drug delivery technologies with higher prices should see greater adoption in coming years.
Tumultuous conditions—the result of product recalls, regulatory scrutiny, broad turnover in the installed base, and economic headwinds—have characterized the market for medication delivery in recent years and led to important shifts in the competitive landscape. Efforts to improve the safety and effectiveness of infusion pumps have coincided with innovations in vascular access and injection, and the result has been a climate of innovation which fosters greater efficiencies in care delivery (e.g., placing central lines without X-ray confirmation) as well as improvements in software and connectivity.
Greater access to healthcare services, the increasing prevalence of diabetes, and product innovation will give rise to a dynamic market for infusion and injection technologies. Manufacturers who offer devices that limit errors and facilitate greater efficiency should be able to reap the rewards of the growing caseloads projected in LSI's new Global Drug Delivery Market Report.
The report covers global markets for the period 2013-2020 and provides competitive analyses, key market metrics, and forecasts for infusion pumps and related disposables; central and peripheral vascular access devices; and injection pens and syringes. Industry competitors include Abbott Nutrition, Advanced Infusion, ambIT, Angiodynamics, B. Braun Melsungen, Baxter Healthcare, BD Medical, Bioject, CR Bard, CareFusion, CME America, Cook Medical, CORPAK MedSystems, Edwards Lifesciences, Eli Lilly, Endo Pharmaceuticals, F. Hoffmann-La Roche, FlexiCath, Fresenius Kabi, Halyard Health, Hospira, Insulet Corporation, Johnson & Johnson, Medtronic, Moog, Nestle Nutrition, Novo Nordisk, PharmaJet, Retractable Technologies, Sanofi, Smiths Medical, Stryker, Tandem Diabetes Care, Teleflex Medical, Terumo, VanishPoint, and Vygon.
For details on LSI's new Drug Delivery Market Report click here.
Contact:
Scott Pantel
[email protected]
714 847 3540
About Life Science Intelligence
Life Science Intelligence (LSI) delivers high-quality global market intelligence products to medical technology executives, entrepreneurs, and investors. LSI provides custom research services, publishes global market reports and procedure volume databases, tracks emerging medtech companies, and hosts the annual Emerging Medical Technologies Summit.
SOURCE Life Science Intelligence
Related Links
http://www.LifeScienceIntelligence.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article